Seagen is now part of Pfizer! Please visit Pfizer.com for more information.
Learn more on Pfizer.com/Seagen
Seagen is a global biotechnology company dedicated to revolutionizing cancer care. We’re developing transformative therapies that make a meaningful difference in people’s lives.
As a pioneer in antibody-drug conjugates (ADCs), Seagen has led the way in novel cancer therapeutics for more than 20 years. We’re committed to discovering safe and effective solutions to challenging clinical needs. Today, our research efforts are dedicated to advancing a pipeline of innovative therapies for solid tumours and blood-related cancers.
SEAGEN SPAIN, S.L.U.
Avenida de Bruselas, 7,
28108 Alcobendas, Madrid,
Spain
Telephone: +34 910 784019
Email: OfficeES@seagen.com
Registered at the commercial registry of Madrid at tome 40,246, Sheet 111, Page M-715,055 VAT ESB88589312
Seagen’s group Code of Ethics and Business Conduct can be found here.
For medical information contact
(+34) 919 011 012
medinfoEU@seagen.com
